SAN DIEGO, CA / ACCESS Newswire / May 27, 2025 /Bora Biologics, a leading contract development and manufacturing organization ...

Single-Use Bioreactors Market is Segmented by Type (Wave-induced Motion SUBs, Stirred SUBs), by Application (R&D, ...

Bora Biologics, a subsidiary of Tanvex Biopharma born out of a spinoff from Bora Pharmaceuticals, is expanding CDMO operations at its San Diego facility. The new project will add 8,075 square feet of ...

Bora Biologics, a contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, is ...

The Global Single-use Bioreactors Market is set to witness a healthy growth rate of 20% by 2029. Technological innovations ...

Medical bioreactor market is growing due to rising demand for biopharmaceuticals, advancements in cell culture technologies, ...

Key Trends and Market Drivers for 2025–2030 Global Market Forecast: Growth Projections and Regional Hotspots Latest Technological Innovations in Isopropanol Biodegradation Leading Companies and ...

Sunflower Therapeutics (Sunflower), a public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, announced today the first system delivery and ...

Bioreactors have become irreplaceable tools ... into pharmaceutical manufacturing using the principles of quality by design. 3 The PAT framework encourages using advanced analytical technologies ...

This design will allow bioprocessing teams to replicate ... Cloud-based bioprocessing is the integration of physical bioreactors with remote data monitoring, automation, and AI-driven optimization ...